Emmanuel Katsanis Selected Research

Emmanuel Katsanis Research Topics

Disease

35	Neoplasms (Cancer) 12/2021 - 12/2002
11	Leukemia 01/2020 - 06/2004
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2016
5	Infections 12/2021 - 07/2012
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2019
3	Breast Neoplasms (Breast Cancer) 03/2022 - 03/2008
3	COVID-19 01/2022 - 01/2021
3	Hematologic Neoplasms (Hematological Malignancy) 04/2021 - 10/2018
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015 - 06/2004
2	Iron Overload 01/2022 - 01/2019
2	Lymphoma (Lymphomas) 01/2018 - 11/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 10/2011
1	Hemolytic Anemia 01/2022
1	Anemia 01/2022
1	Congenital Dyserythropoietic Anemia (Dyserythropoietic Anemia, Congenital) 01/2022
1	Hemochromatosis (Bronze Diabetes) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021
1	Wiskott-Aldrich Syndrome 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Cytopenia 01/2019
1	Splenomegaly 01/2019
1	Hemorrhage 01/2019
1	Hyperammonemia 04/2018
1	Brain Diseases (Brain Disorder) 04/2018
1	Carcinogenesis 10/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2015
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2014
1	Mucolipidoses (Sialidosis) 11/2014
1	Hepatoblastoma 07/2014
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Adenocarcinoma 08/2013
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2011
1	Hyperplasia 10/2011
1	Melanoma (Melanoma, Malignant) 12/2008
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2008
1	Philadelphia Chromosome 11/2008

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 01/2021 - 04/2003
9	AntigensIBA 01/2014 - 03/2006
9	Proteins (Proteins, Gene)FDA Link 01/2014 - 04/2003
5	Bendamustine Hydrochloride FDA Link 04/2021 - 10/2018
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014 - 12/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2016
4	Cancer VaccinesIBA 01/2014 - 04/2003
4	Neoplasm Antigens (Tumor Antigens)IBA 02/2010 - 09/2006
4	Peptides (Polypeptides)IBA 12/2008 - 03/2005
4	SolutionsIBA 03/2006 - 04/2003
3	CytokinesIBA 01/2013 - 01/2003
3	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 03/2006 - 01/2003
2	fludarabineIBA 01/2020 - 11/2016
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 11/2016
2	Busulfan (Busulfex)FDA Link 01/2020 - 11/2016
2	Peroxynitrous Acid (Peroxynitrite)IBA 09/2011 - 02/2010
2	CalreticulinIBA 12/2008 - 12/2006
2	glucose-regulated proteinsIBA 12/2008 - 04/2003
2	Imatinib Mesylate (Gleevec)FDA Link 11/2008 - 06/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007 - 02/2006
2	NF-kappa B (NF-kB)IBA 01/2007 - 09/2006
2	Transcription Factors (Transcription Factor)IBA 01/2007 - 09/2006
1	Interleukin-15 (Interleukin 15)IBA 03/2022
1	Interleukin-7 (Interleukin 7)IBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2022
1	OsteonectinIBA 03/2022
1	MyokinesIBA 03/2022
1	mRNA VaccinesIBA 01/2022
1	Neutralizing AntibodiesIBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	Alkylating AgentsIBA 04/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	blinatumomabIBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019
1	AzolesIBA 01/2019
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	AnthracyclinesIBA 01/2015
1	EnzymesIBA 11/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Biological ProductsIBA 01/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2011
1	Rituximab (Mabthera)FDA Link 10/2011
1	Inosine Triphosphate (ITP)IBA 10/2011
1	Differentiation AntigensIBA 12/2008
1	Phosphotransferases (Kinase)IBA 11/2008
1	Tyrosine (L-Tyrosine)FDA Link 11/2008

Therapy/Procedure

18	Immunotherapy 01/2021 - 04/2003
15	Cell Transplantation 01/2022 - 03/2006
9	Therapeutics 01/2022 - 03/2006
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 10/2018
3	Hematopoietic Stem Cell Transplantation 01/2020 - 11/2014
3	Drug Therapy (Chemotherapy) 07/2014 - 03/2006
2	Transplantation 01/2022 - 01/2020
1	Chelation Therapy (Therapy, Chelation) 01/2022
1	Maintenance Chemotherapy 01/2019
1	Heart Transplantation (Grafting, Heart) 01/2015